Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients.

Stein S, Zhao R, Haeno H, Vivanco I, Michor F.

PLoS Comput Biol. 2018 Jan 2;14(1):e1005924. doi: 10.1371/journal.pcbi.1005924. eCollection 2018 Jan.

2.

Correction: Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.

Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.

PLoS Genet. 2017 May 19;13(5):e1006798. doi: 10.1371/journal.pgen.1006798. eCollection 2017 May.

3.

Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling.

Yamamoto KN, Yachida S, Nakamura A, Niida A, Oshima M, De S, Rosati LM, Herman JM, Iacobuzio-Donahue CA, Haeno H.

Cancer Res. 2017 Jun 15;77(12):3325-3335. doi: 10.1158/0008-5472.CAN-16-1208. Epub 2017 Apr 5.

PMID:
28381541
4.

Prediction of postoperative liver regeneration from clinical information using a data-led mathematical model.

Yamamoto KN, Ishii M, Inoue Y, Hirokawa F, MacArthur BD, Nakamura A, Haeno H, Uchiyama K.

Sci Rep. 2016 Oct 3;6:34214. doi: 10.1038/srep34214.

5.

Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution.

Uchi R, Takahashi Y, Niida A, Shimamura T, Hirata H, Sugimachi K, Sawada G, Iwaya T, Kurashige J, Shinden Y, Iguchi T, Eguchi H, Chiba K, Shiraishi Y, Nagae G, Yoshida K, Nagata Y, Haeno H, Yamamoto H, Ishii H, Doki Y, Iinuma H, Sasaki S, Nagayama S, Yamada K, Yachida S, Kato M, Shibata T, Oki E, Saeki H, Shirabe K, Oda Y, Maehara Y, Komune S, Mori M, Suzuki Y, Yamamoto K, Aburatani H, Ogawa S, Miyano S, Mimori K.

PLoS Genet. 2016 Feb 18;12(2):e1005778. doi: 10.1371/journal.pgen.1005778. eCollection 2016 Feb. Erratum in: PLoS Genet. 2017 May 19;13(5):e1006798.

6.

The evolution of tumor metastasis during clonal expansion with alterations in metastasis driver genes.

Yamamoto KN, Nakamura A, Haeno H.

Sci Rep. 2015 Oct 30;5:15886. doi: 10.1038/srep15886.

7.

Bacterial c-di-GMP affects hematopoietic stem/progenitors and their niches through STING.

Kobayashi H, Kobayashi CI, Nakamura-Ishizu A, Karigane D, Haeno H, Yamamoto KN, Sato T, Ohteki T, Hayakawa Y, Barber GN, Kurokawa M, Suda T, Takubo K.

Cell Rep. 2015 Apr 7;11(1):71-84. doi: 10.1016/j.celrep.2015.02.066. Epub 2015 Apr 2.

8.

Evolution of pre-existing versus acquired resistance to platinum drugs and PARP inhibitors in BRCA-associated cancers.

Yamamoto KN, Hirota K, Takeda S, Haeno H.

PLoS One. 2014 Aug 26;9(8):e105724. doi: 10.1371/journal.pone.0105724. eCollection 2014.

9.

Stochastic Tunneling of Two Mutations in a Population of Cancer Cells.

Haeno H, Maruvka YE, Iwasa Y, Michor F.

PLoS One. 2013 Jun 26;8(6):e65724. doi: 10.1371/journal.pone.0065724. Print 2013.

10.

A race between tumor immunoescape and genome maintenance selects for optimum levels of (epi)genetic instability.

Iwami S, Haeno H, Michor F.

PLoS Comput Biol. 2012;8(2):e1002370. doi: 10.1371/journal.pcbi.1002370. Epub 2012 Feb 16.

11.

Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies.

Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F.

Cell. 2012 Jan 20;148(1-2):362-75. doi: 10.1016/j.cell.2011.11.060.

12.

The probable cell of origin of NF1- and PDGF-driven glioblastomas.

Hambardzumyan D, Cheng YK, Haeno H, Holland EC, Michor F.

PLoS One. 2011;6(9):e24454. doi: 10.1371/journal.pone.0024454. Epub 2011 Sep 9.

13.

A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia.

Klinakis A, Lobry C, Abdel-Wahab O, Oh P, Haeno H, Buonamici S, van De Walle I, Cathelin S, Trimarchi T, Araldi E, Liu C, Ibrahim S, Beran M, Zavadil J, Efstratiadis A, Taghon T, Michor F, Levine RL, Aifantis I.

Nature. 2011 May 12;473(7346):230-3. doi: 10.1038/nature09999.

14.

The evolution of tumor metastases during clonal expansion.

Haeno H, Michor F.

J Theor Biol. 2010 Mar 7;263(1):30-44. doi: 10.1016/j.jtbi.2009.11.005. Epub 2009 Nov 14.

15.

A progenitor cell origin of myeloid malignancies.

Haeno H, Levine RL, Gilliland DG, Michor F.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16616-21. doi: 10.1073/pnas.0908107106. Epub 2009 Sep 21.

16.

The evolution of two mutations during clonal expansion.

Haeno H, Iwasa Y, Michor F.

Genetics. 2007 Dec;177(4):2209-21.

17.

Probability of resistance evolution for exponentially growing virus in the host.

Haeno H, Iwasa Y.

J Theor Biol. 2007 May 21;246(2):323-31. Epub 2007 Jan 23.

PMID:
17306832

Supplemental Content

Support Center